Literature DB >> 11493395

Infectious complications of lung transplantation.

B D Alexander1, V F Tapson.   

Abstract

Lung transplantation is associated with a high incidence of infection which directly impacts the morbidity and mortality associated with the procedure. In addition, these infections may also have immunologic consequences that play a role in the evolution of lung injury syndromes, resulting in earlier loss of graft than otherwise would be expected to occur. Although bacteria are responsible for the majority of infections following lung transplantation, fungal infections are associated with the highest mortality. This paper is an overview of the major infectious complications encountered in the lung transplant population. The epidemiology, prophylaxis, and treatment of infections following lung transplantation are critical areas for continued research.

Entities:  

Mesh:

Year:  2001        PMID: 11493395     DOI: 10.1034/j.1399-3062.2001.003003128.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  17 in total

1.  Posaconazole Tablets in Real-Life Lung Transplantation: Impact on Exposure, Drug-Drug Interactions, and Drug Management in Lung Transplant Patients, Including Those with Cystic Fibrosis.

Authors:  Manon Launay; Antoine Roux; Laurence Beaumont; Benoit Douvry; Lucien Lecuyer; Emmanuel Douez; Clément Picard; Dominique Grenet; Vincent Jullien; Véronique Boussaud; Romain Guillemain; Eliane M Billaud
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 2.  Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.

Authors:  Michael D Duncan; David S Wilkes
Journal:  Proc Am Thorac Soc       Date:  2005

Review 3.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

4.  Understanding the Concept of Health Care-Associated Pneumonia in Lung Transplant Recipients.

Authors:  Federico Palacio; Luis F Reyes; Deborah J Levine; Juan F Sanchez; Luis F Angel; Juan F Fernandez; Stephanie M Levine; Jordi Rello; Ali Abedi; Marcos I Restrepo
Journal:  Chest       Date:  2015-08       Impact factor: 9.410

Review 5.  Perioperative antibiotics in thoracic surgery.

Authors:  Stephanie H Chang; Alexander S Krupnick
Journal:  Thorac Surg Clin       Date:  2011-10-20       Impact factor: 1.750

6.  Incidence, Risk Factors and Outcomes of Delayed-onset Cytomegalovirus Disease in a Large Retrospective Cohort of Lung Transplant Recipients.

Authors:  Carlos A Q Santos; Daniel C Brennan; Roger D Yusen; Margaret A Olsen
Journal:  Transplantation       Date:  2015-08       Impact factor: 4.939

7.  Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation.

Authors:  Laurie D Snyder; C Ashley Finlen-Copeland; W Jackson Turbyfill; David Howell; Daniel A Willner; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2010-02-18       Impact factor: 21.405

8.  Long term complications following 54 consecutive lung transplants.

Authors:  Walther Tabarelli; Hugo Bonatti; Dominique Tabarelli; Miriam Eller; Ludwig Müller; Elfriede Ruttmann; Cornelia Lass-Flörl; Clara Larcher; Christian Geltner
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

9.  The Prevalence of Pneumocystis jiroveci in Bronchoalveolar Lavage Specimens of Lung Transplant Recipients Examined by the Nested PCR.

Authors:  Morteza Izadi; Nematollah Jonaidi Jafari; Javid Sadraei; Abbas Mahmoodzadeh Poornaki; Babak Rezavand; Hossein Zarrinfar; Jahangir Abdi; Younes Mohammadi
Journal:  Jundishapur J Microbiol       Date:  2014-12-01       Impact factor: 0.747

10.  Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study.

Authors:  M Winkler; J Pratschke; U Schulz; S Zheng; M Zhang; W Li; M Lu; D Sgarabotto; G Sganga; P Kaskel; S Chandwani; L Ma; J Petrovic; M Shivaprakash
Journal:  Transpl Infect Dis       Date:  2010-01-11       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.